Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness

J. S. Jin, C. P. Yu, G. H. Sun, Y. F. Lin, H. Chiang, T. K. Chao, W. C. Tsai, L. F. Sheu

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Aim: To determine whether higher expression of fascin, an actin-bundling protein associated with motility, in conventional renal cell carcinoma (RCC) is associated with more advanced stages of the disease. Methods: Immunohistochemical analysis of fascin expression was performed in tissue microarrays of 108 RCCs including 55 clear cell RCCs (CRCCs), 39 CRCCs with granular cell differentiation (GRCCs), 8 CRCCs with sarcomatoid differentiation (SRCCs) and 6 metastatic RCCs. Results: The expression of fascin was undetectable in normal renal tubules of all control cases. However, among the 108 RCC cases, fascin immunoreactivity was seen on the cell membrane and cytoplasm. The average immunostaining score for fascin was 128/400 in grade I, 170/400 in grade 11, 207/400 in grade III, and 323/400 in grade IV RCC. The average immunostaining score of fascin was 187/400 for stage T1, 205/400 for stage T2, 288/400 for stage T3, and 355/400 for stage T4 cases of RCCs. Higher fascin scores in RCC were significantly correlated with higher T and N stages and nuclear grade. In addition, the fascin scores in GRCC (368±19) and SRCC (263±21) were significantly higher than in CRCC (95±18). Conclusions: Our findings demonstrate for the first time that increased expression of fascin is associated with clinicopathological parameters of aggressiveness in patients with RCC. Fascin may novel biomarker for diagnosis and treatment of RCC.

Original languageEnglish
Pages (from-to)1287-1293
Number of pages7
JournalHistology and Histopathology
Volume21
Issue number10-12
Publication statusPublished - Oct 2006
Externally publishedYes

Fingerprint

Renal Cell Carcinoma
fascin
Actins
Cell Differentiation
Cytoplasm
Biomarkers
Cell Membrane
Kidney

Keywords

  • Clear cell type
  • Fascin
  • Granular cell differentiation
  • Renal cell carcinoma
  • Sarcomatoid differentiation

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Histology
  • Cell Biology

Cite this

Jin, J. S., Yu, C. P., Sun, G. H., Lin, Y. F., Chiang, H., Chao, T. K., ... Sheu, L. F. (2006). Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness. Histology and Histopathology, 21(10-12), 1287-1293.

Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness. / Jin, J. S.; Yu, C. P.; Sun, G. H.; Lin, Y. F.; Chiang, H.; Chao, T. K.; Tsai, W. C.; Sheu, L. F.

In: Histology and Histopathology, Vol. 21, No. 10-12, 10.2006, p. 1287-1293.

Research output: Contribution to journalArticle

Jin, JS, Yu, CP, Sun, GH, Lin, YF, Chiang, H, Chao, TK, Tsai, WC & Sheu, LF 2006, 'Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness', Histology and Histopathology, vol. 21, no. 10-12, pp. 1287-1293.
Jin, J. S. ; Yu, C. P. ; Sun, G. H. ; Lin, Y. F. ; Chiang, H. ; Chao, T. K. ; Tsai, W. C. ; Sheu, L. F. / Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness. In: Histology and Histopathology. 2006 ; Vol. 21, No. 10-12. pp. 1287-1293.
@article{d35825f20d9e40de921715bc06f8f95b,
title = "Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness",
abstract = "Aim: To determine whether higher expression of fascin, an actin-bundling protein associated with motility, in conventional renal cell carcinoma (RCC) is associated with more advanced stages of the disease. Methods: Immunohistochemical analysis of fascin expression was performed in tissue microarrays of 108 RCCs including 55 clear cell RCCs (CRCCs), 39 CRCCs with granular cell differentiation (GRCCs), 8 CRCCs with sarcomatoid differentiation (SRCCs) and 6 metastatic RCCs. Results: The expression of fascin was undetectable in normal renal tubules of all control cases. However, among the 108 RCC cases, fascin immunoreactivity was seen on the cell membrane and cytoplasm. The average immunostaining score for fascin was 128/400 in grade I, 170/400 in grade 11, 207/400 in grade III, and 323/400 in grade IV RCC. The average immunostaining score of fascin was 187/400 for stage T1, 205/400 for stage T2, 288/400 for stage T3, and 355/400 for stage T4 cases of RCCs. Higher fascin scores in RCC were significantly correlated with higher T and N stages and nuclear grade. In addition, the fascin scores in GRCC (368±19) and SRCC (263±21) were significantly higher than in CRCC (95±18). Conclusions: Our findings demonstrate for the first time that increased expression of fascin is associated with clinicopathological parameters of aggressiveness in patients with RCC. Fascin may novel biomarker for diagnosis and treatment of RCC.",
keywords = "Clear cell type, Fascin, Granular cell differentiation, Renal cell carcinoma, Sarcomatoid differentiation",
author = "Jin, {J. S.} and Yu, {C. P.} and Sun, {G. H.} and Lin, {Y. F.} and H. Chiang and Chao, {T. K.} and Tsai, {W. C.} and Sheu, {L. F.}",
year = "2006",
month = "10",
language = "English",
volume = "21",
pages = "1287--1293",
journal = "Histology and Histopathology",
issn = "0213-3911",
publisher = "Histology and Histopathology",
number = "10-12",

}

TY - JOUR

T1 - Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness

AU - Jin, J. S.

AU - Yu, C. P.

AU - Sun, G. H.

AU - Lin, Y. F.

AU - Chiang, H.

AU - Chao, T. K.

AU - Tsai, W. C.

AU - Sheu, L. F.

PY - 2006/10

Y1 - 2006/10

N2 - Aim: To determine whether higher expression of fascin, an actin-bundling protein associated with motility, in conventional renal cell carcinoma (RCC) is associated with more advanced stages of the disease. Methods: Immunohistochemical analysis of fascin expression was performed in tissue microarrays of 108 RCCs including 55 clear cell RCCs (CRCCs), 39 CRCCs with granular cell differentiation (GRCCs), 8 CRCCs with sarcomatoid differentiation (SRCCs) and 6 metastatic RCCs. Results: The expression of fascin was undetectable in normal renal tubules of all control cases. However, among the 108 RCC cases, fascin immunoreactivity was seen on the cell membrane and cytoplasm. The average immunostaining score for fascin was 128/400 in grade I, 170/400 in grade 11, 207/400 in grade III, and 323/400 in grade IV RCC. The average immunostaining score of fascin was 187/400 for stage T1, 205/400 for stage T2, 288/400 for stage T3, and 355/400 for stage T4 cases of RCCs. Higher fascin scores in RCC were significantly correlated with higher T and N stages and nuclear grade. In addition, the fascin scores in GRCC (368±19) and SRCC (263±21) were significantly higher than in CRCC (95±18). Conclusions: Our findings demonstrate for the first time that increased expression of fascin is associated with clinicopathological parameters of aggressiveness in patients with RCC. Fascin may novel biomarker for diagnosis and treatment of RCC.

AB - Aim: To determine whether higher expression of fascin, an actin-bundling protein associated with motility, in conventional renal cell carcinoma (RCC) is associated with more advanced stages of the disease. Methods: Immunohistochemical analysis of fascin expression was performed in tissue microarrays of 108 RCCs including 55 clear cell RCCs (CRCCs), 39 CRCCs with granular cell differentiation (GRCCs), 8 CRCCs with sarcomatoid differentiation (SRCCs) and 6 metastatic RCCs. Results: The expression of fascin was undetectable in normal renal tubules of all control cases. However, among the 108 RCC cases, fascin immunoreactivity was seen on the cell membrane and cytoplasm. The average immunostaining score for fascin was 128/400 in grade I, 170/400 in grade 11, 207/400 in grade III, and 323/400 in grade IV RCC. The average immunostaining score of fascin was 187/400 for stage T1, 205/400 for stage T2, 288/400 for stage T3, and 355/400 for stage T4 cases of RCCs. Higher fascin scores in RCC were significantly correlated with higher T and N stages and nuclear grade. In addition, the fascin scores in GRCC (368±19) and SRCC (263±21) were significantly higher than in CRCC (95±18). Conclusions: Our findings demonstrate for the first time that increased expression of fascin is associated with clinicopathological parameters of aggressiveness in patients with RCC. Fascin may novel biomarker for diagnosis and treatment of RCC.

KW - Clear cell type

KW - Fascin

KW - Granular cell differentiation

KW - Renal cell carcinoma

KW - Sarcomatoid differentiation

UR - http://www.scopus.com/inward/record.url?scp=33750353401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750353401&partnerID=8YFLogxK

M3 - Article

C2 - 16977579

AN - SCOPUS:33750353401

VL - 21

SP - 1287

EP - 1293

JO - Histology and Histopathology

JF - Histology and Histopathology

SN - 0213-3911

IS - 10-12

ER -